GoodGut has presented positive results for the RAID-CRC test, which will improve early detection of colorectal cancer (CRC). This test yields 55% fewer false positives than screening with faecal occult blood tests. These conclusions are from a multi-centre study with 450 at five benchmark hospitals in Catalonia.

Dr Antoni Castells, co-coordinator of the Barcelona colorectal cancer detection programme, says the new approach would "if these results are confirmed among participants in screening programs we can reduce the number of unnecessary colonoscopies by 32% and detect 59% of precancerous lesions". CRC is the third most common form of cancer in occurrence and mortality rate in the world, according to the World Health Organisation (WHO).

Biotech company has opened an investment round of 4 million euros to bring the test to the market by the end of 2019.

More information is available on the GoodGut website.

Photo: Jaume Amat, Mariona Serra, Xavier Aldeguer and Jesús Garcia-Gil, the management team of GoodGut - © GoodGut.